Ca2+channel | Cell type | Mechanisms and effectors | References |
---|---|---|---|
Store-dependent SOC channels | |||
STIM1-Orai1 | • Human cervical cancer SiHa and CaSki cells | • Increase in EGF-stimulated cellular migration and invasion | |
• Increase in focal adhesion dynamics through the Ca2+-regulated protease calpain and cytoplasmic kinase Pyk2 | |||
• Upregulation of EGF-induced MLC phosphorylation and actomyosin reorganization | |||
• Upregulation of VEGF production | |||
• Promotion of tumor growth and angiogenesis in a xenograft mice model | |||
 | • Human breast cancer MDA-MB-231 cells and mouse mammary tumor 4 T1 cells | • Increase in serum-induced cellular migration and invasion | [31] |
• Increase in focal adhesion turnover rates through Ras and Rac1 | |||
• Promotion of tumor growth and metastasis in a xenograft mice model | |||
STIM-Orai3 | • Human breast cancer MCF7 cells (ER+ breast cancer cells) | • Increase in anchorage-independent growth and Matrigel invasion | |
 |  | • Increase in tumorigenesis in a xenograft mice model |  |
Store-independent SOC channel | |||
SPCA2-Orai1 | • Human breast cancer MCF-7 cells | • Constitutively active store-independent Ca2+ influx | [34] |
• Promotion of proliferation and colony formation | |||
 |  | • Increase in tumorigenesis in a xenograft mice model |  |
TRP channels | |||
TRPM1 | • Murine melanoma B16-F1 cells | • Reduce in tumor metastasis | |
TRPM7 | • Human breast cancer MDA-MB-231 cells and MEF cells | • Increase in cellular migration | |
• Guidance of polarized cellular migration | |||
• Increase in peripheral focal adhesion turnovers through the Ca2+-regulated protease m-calpain | |||
• Inhibition of myosin II-based cell contractility | |||
• Increase in tumorigenesis in a xenograft mice model | |||
 | • Human nasopharyngeal cancer 5-8 F and 6-10B cells | • Increase in cellular migration | [40] |
 | • Human lung cancer A549 cells | • Increase in EGF-stimulated cellular migration | [38] |
TRPM8 | • Human prostate cancer PC-3 cells | • Decrease in cellular migration | |
• Inactivation of FAK | |||
TRPV1 | • Human hepatoblastoma HepG2 cells | • Increase in HGF-stimulated cellular migration | |
TRPV2 | • Human prostate cancer LNCaP and PC-3 cells | • Increase in cellular migration and invasion | [45] |
• Induction of invasive enzymes MMP-2, MMP-9 and cathepsin B | |||
• Increase in tumorigenesis in a xenograft mice model | |||
TRPC6 | • Human glioblastoma cells | • Increase in cell proliferation through regulation of CDK1 activation and Cdc25C expression | |
• Increase in anchorage-independent growth and Matrigel invasion | |||
• Increase in endothelial cell tube formation | |||
 |  | • Increase in tumorigenesis in a xenograft mice model |  |